Biofluids in orofacial pain: Review

Shweta Gupta; Manish Sharma; Manish Kumar; Uma Dabla; Satya Prakash; Vidhi Sangra

doi:10.53730/ijhs.v6nS3.6475

Authors

Shweta Gupta
shwetagupta2012@gmail.com
Pg Student, Dept. of Oral Pathology, Surendera Dental College & Research Institute Sriganganagar Rajasthan
Manish Sharma Prof & Head, Dept. Of Oral Pathology, Surendera Dental College & Research Institute Sriganganagar, Rajasthan
Manish Kumar Reader, Dept. Of Oral Pathology, Surendera Dental College & Research Institute Sriganganagar, Rajasthan
Uma Dabla BDS,MDS, Dept of Oral Pathology
Satya Prakash Senior lecturer, Oral and Maxillofacial Surgeon, J. C. D Dental College Sirsa, Haryana
Vidhi Sangra BDS, MDS, Oral and Maxillofacial Surgery

Keywords:

biofluid, biomarkers, neural pain, serum, saliva

Abstract

Orofacial pain is a dental specialty that focuses on diagnosing and treating long-term, complicated facial discomfort caused by oromotor disorders. This pain is similar to pain elsewhere in the body and is generally caused by tissue damages. The pathogenesis of orofacialpain might be caused by orofacial structures illness, musculoskeletal system disorders, peripheral or central nervous system disorders, systemic diseases, psychological problems, or the result of inadequate sleep. One method to diagnose is evaluating the molecular and microbial cues of biological fluids, which may indicate the occurrence or progression of the disease. This article provides an overview of these biofluids and biomarkers and their role in progression of orofacial diseases.

Downloads

Download data is not yet available.

References

Conti PC, Pertes RA, Heir GM, Nasri C, Cohen HV, Araújo Cdos R. Orofacial pain: basic mechanisms and implication for successful management. J Appl Oral Sci. 2003;11(1):1-7. doi:10.1590/s1678-77572003000100002.

S. Katsiougiannis, PhD V.R. Mallela, BDS, DDS C.A. Schafer, BS, MBA, PhD University of California Los Angeles, School of Dentistry, 10833 Le Conte Ave., 73-041 CHS, Los Angeles, CA, 90095, USA

Aronson, J.K., & Ferner, R.E. (2017). Biomarkers—A general review. Current Protocols in Pharmacology, 76, 9.23.1-9.23.17. doi: 10.1002/cpph.19

American Academy of Orofacial Pain. The scope of TMD/ orofacial pain (head and neck pain management) in contemporary dental practice. Dental Practice Act Committee of the American Academy of Orofacial Pain. J Orofac Pain 1997; 11(1):78-83.

Vickers ER. Cousins MJ. Neuropathic orofacial pain part 1— prevalence and pathophysiology. Aust Endod J 2000, 26(1):19- 26

Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, et al. The human serum metabolome. PLoS One. 2011;6(2):e16957. doi:10.1371/journal.pone. 0016957

Aronson, J. K. (2005). Biomarkers and surrogate endpoints. British Journal of Clinical Pharmacology, 59, 491-494. doi: 10.1111/ j.1365-2125.2005.02435.x

Fox SI (1999) Human physiology. BostonMass.: WCB/McGraw-Hill. pp 364–367.

Martini F, Ober WC (2006) Fundamentals of anatomy & physiology. San FranciscoCA: Pearson Benjamin Cummings. pp 640–643.

Grant GH, Butt WR (1970) Immunochemical methods in clinical chemistry. Adv Clin Chem 13: 383–466.

Lentner C (1981) Physical Chemistry, Composition of Blood, Hematology, Somatometric Data. In: Lentner C, ed. Geigy Scientific Tables. 8th ed. West Caldwell, NJ. pp 165–177

West JB, ed. (1985) Best and Taylor’s Physiological Basis of Medical Practice. 11th ed. Baltimore MD, USA: Waverly Press, Inc. pp 334–336.

Malamud D. Saliva as a diagnostic fluid. Dent Clin North Am. 2011;55(1):159-178. doi:10.1016/j.cden.2010.08.004

Farnaud SJ, Kosti O, Getting SJ, et al. Saliva: physiology and diagnostic potential in health and disease. Scientific World Journal 2010;10:434–56

Corstjens PLAM, Malamud D. Point-of-care diagnostics for infectious diseases. In: Wong DT, editor. Saliva diagnostics. Ames (IA): Wiley-Blackwell; 2008. p. 243–54.

Edgar WM. Saliva: its secretion, composition and functions. Br Dent J. 1992;172(8):305–12.

Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner ACR, Yu W-H, et al. The human oral microbiome. J Bacteriol. 2010;192(19):5002–17. doi:10.1128/jb. 00542-10.

Park NJ, Li Y, Yu T, Brinkman BMN, Wong DT. Characterization of RNA in Saliva. Clin Chem. 2006;52(6):988–94. doi:10.1373/clinchem.2005. 063206.

Fu K, Ma X, Zhang Z, Chen W. Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg. 1995;53(4):424-426. doi:10.1016/0278-2391(95)90717-3

Doshi TL, Nixdorf DR, Campbell CM, Raja SN. Biomarkers in Temporomandibular Disorder and Trigeminal Neuralgia: A Conceptual Framework for Understanding Chronic Pain. Can J Pain. 2020;4(1):1-18. doi:10.1080/24740527.2019.1709163

McNearney T, Baethge BA, Cao S, Alam R, Lisse JR, Westlund KN. Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol. 2004;137(3):621-627. doi:10.1111/j.1365-2249.2004.02563.x

Biomarkers Definitions Working G. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89– 95. doi:10.1067/mcp.2001.113989.

Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5(6):463–6. doi:10.1097/ COH.0b013e32833ed177.

Tina L. Doshi, Donald R. Nixdorf, Claudia M. Campbell & Srinivasa N. Raja (2020) Biomarkers in temporomandibular disorder and trigeminal neuralgia: A conceptual framework for understanding chronic pain, Canadian Journal of Pain, 4:1, 1-18, DOI: 10.1080/24740527.2019.1709163

Smith SM, Dworkin RH, Turk DC, et al. The potential role of sensory testing, skin biopsy, and functional brain imaging as biomarkers in chronic pain clinical trials: IMMPACT considerations. J Pain. 2017;18(7):757–777. doi:10.1016/j.jpain.2017.02.429

Leal LB, Nogueira MS, Canevari RA, Carvalho LFCS. Vibration spectroscopy and body biofluids: Literature review for clinical applications. Photodiagnosis Photodyn Ther. 2018;24:237-244. doi:10.1016/j.pdpdt.2018.09.008

Santos, P. C. J. L. & Junior, P. C. Atenção farmacêutica: contexto atual, exames laboratoriais eacompanhamento farmacoterapêutico.Atheneu, 2016; 1:452.

Bonnier, F.; Petijean, F.; Baker, M. J.; Byrne, H. J. Improved protocols for vibrational spectroscopic analysis of body fluids.J.Biophotonics, 2014;7(3-4): 167-179.

Sumita, Nm & Mendes Me. O que está por trás de um laudo laboratorial de qualidade?. Ano 17, Num. 06. Roche News, 2015

Baker, J. M.; Hussain, S. R.; Lovergne, L.; Untereiner, V.; Hughes, C.; et al. Developing and understanding biofluid vibrational spectroscopy: a critical review. Chem. Soc. Rev., 2015; 45(7): 1803-1818

Xia J, Lin M, Jin Z. Correlations among mood disorder, serum interleukin-2 and interleukin-6 in patients with burning mouth syndrome. Hua Xi Kou Qiang Yi Xue Za Zhi. 2003;21(5):377–8

.Boras VV, Savage NW, Brailo V, Lukac J, Lukac M, Alajbeg IZ. Salivary and serum levels of substance P, neurokinin A and calcitonin gene related peptide in burning mouth syndrome. Med Oral Patol Oral Cir Bucal. 2010;15(3):e427–31.

Slade GD, Conrad MS, Diatchenko L, Rashid NU, Zhong S, Smith S et al. Cytokine biomarkers and chronic pain: association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tendernessPain.2011;152(12):2802–12. doi:http://dx.doi.org/10.1016/j.pain.2011.09.005

Yoshida K, Takatsuka S, Hatada E, Nakamura H, Tanaka A, Ueki K, et al. Expression of matrix metalloproteinases and aggrecanase in the synovial fluids of patients with symptomatic temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(1):22–7. doi:10.1016/j.tripleo.2005. 07.013

Mirrielees J, Crofford LJ, Lin Y, Kryscio RJ, Dawson Iii DR, Ebersole JL, et al. Rheumatoid arthritis and salivary biomarkers of periodontal disease. J Clin Periodontol. 2010;37(12):1068–74. doi:10.1111/ j.1600-051X.2010.01625.x.